Search

everythinglearnresearchcommunity

for

Search:↓

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

A woman with Parry-Romberg syndrome developed new curly hair on one side of her scalp, a condition not previously linked to the syndrome.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Rosemary extracts with carnosic acid and carnosol can reduce the harmfulness of Staphylococcus aureus without stopping its growth.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Topical latanoprost and bimatoprost eye solutions don't help eyelash growth in people with alopecia areata.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.